| Risk factor | Acute ST OR (95% CI) | Early ST OR (95% CI) | Late ST OR (95% CI) | VLST OR (95% CI) |
|---|---|---|---|---|
| Discontinued dual antiplatelet therapy | N/A | 3.49 (2.17-5.30) | 3.44 (2.09-5.36) | 1.75 (0.97-2.92) |
| Bifurcation lesion PCI | 1.62 (1.17-2.19) | 1.66 (1.18-2.26) | 1.57 (1.00-2.34) | 1.39 (0.92-2.01) |
| Incomplete stent expansion | 1.63 (1.08-2.38) | 1.73 (1.14-2.55) | 1.91 (1.19-2.94) | 1.54 (0.98-2.31) |
| Undersized stent relative to vessel | 1.95 (1.18-3.03) | 2.00 (1.24-3.07) | 1.91 (1.17-2.96) | N/A |
| Diabetes mellitus | 1.62 (1.24-2.07) | 1.69 (1.29-2.18) | 1.53 (1.08-2.10) | 1.61 (1.04-2.36) |